UCSF

Brian Alldredge, PharmD

Vice Provost-Academic Affairs
Professor
Office of the Executive Vice Chancellor & Provost
Alldredge
Susan Merrell
[email protected]
Phone: +1 415 514-0421
Fax: +1 415 514-0200
513 Parnassus Avenue, MSB, Rm 101
UCSF Box 0401
San Francisco, CA 94143
United States

Links

UCSF Profiles

Affiliations

Joint appointments

Department of Neurology

UCSF centers, institutes, and research programs

UCSF Epilepsy Center

What I do

My clinical practice and research focus on the drug treatment of epilepsy and the genetic, behavioral, and environmental factors that influence drug response.

Departmental research area

clinical research

My research expertise

personalized medicine, pharmacogenomics, evidence-based health care, medication safety, pharmacokinetics, pharmacodynamics

Clinical expertise

neurology, epilepsy, pharmacogenetics

Professional background

Degrees

PharmD, University of California, San Francisco, 1984
BS, Chemistry, University of California, Los Angeles, 1980

Licensure and certifications

Licentiate in Pharmacy, State Board of Pharmacy, 1984

Biography

Brian Alldredge is a clinician-educator-researcher with research and clinical interests in epilepsy, seizure emergencies, pharmacogenomics, and pharmacy education. He serves as Vice Provost-Academic Affairs for the UCSF campus and he holds joint appointments as a professor of clinical pharmacy in the School of Pharmacy and a clinical professor in the Department of Neurology in the School of Medicine.

Research keywords

  • Phytotherapy
  • Organizational Culture
  • Central Nervous System Infections
  • Antimanic Agents
  • Safety Management
  • epilepsy
  • Medical Errors
  • United States Agency for Healthcare Research and Quality
  • pharmacists
  • Professional Role
  • Status Epilepticus
  • Anticonvulsants
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Drugs, Generic
  • pharmacy

Publications

Tsoh JY, Kuo AK, Barr JW, Whitcanack L, Merry I, Alldredge BK, Azzam AN. Developing faculty leadership from 'within': a 12-year reflection from an internal faculty leadership development program of an academic health sciences center. Med Educ Online. 2019 Dec; 24(1):1567239.
Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, Bare M, Bleck T, Dodson WE, Garrity L, Jagoda A, Lowenstein D, Pellock J, Riviello J, Sloan E, Treiman DM. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb; 16(1):48-61.
Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Neurobiol Dis. 2015 May; 77:127-40.
Alldredge BK, Kayser SR. In reply. JAMA Intern Med. 2013 Aug 12; 173(15):1473.
Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. Nature. 2013 Sep 12; 501(7466):217-21.
Riviello JJ, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, Glauser T, Shutter L, Treiman DM, Vespa PM, Bell R, Brophy GM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
Alldredge BK, Kayser SR. Bending the curve toward increased use of generic drugs. JAMA Intern Med. 2013 Feb 11; 173(3):233-4.
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012 Aug; 17(1):3-23.
Auerbach AD, Sehgal NL, Blegen MA, Maselli J, Alldredge BK, Vittinghoff E, Wachter RM. Effects of a multicentre teamwork and communication programme on patient outcomes: results from the Triad for Optimal Patient Safety (TOPS) project. BMJ Qual Saf. 2012 Feb; 21(2):118-26.
Blegen MA, Gearhart S, O'Brien R, Sehgal NL, Alldredge BK. AHRQ's hospital survey on patient safety culture: psychometric analyses. J Patient Saf. 2009 Sep; 5(3):139-44.
Kaiboriboon K, Guevara M, Alldredge BK. Understanding herb and dietary supplement use in patients with epilepsy. Epilepsia. 2009 Aug; 50(8):1927-32.
Sehgal NL, Fox M, Vidyarthi AR, Sharpe BA, Gearhart S, Bookwalter T, Barker J, Alldredge BK, Blegen MA, Wachter RM, Triad for Optimal Patient Safety Project. A multidisciplinary teamwork training program: the Triad for Optimal Patient Safety (TOPS) experience. J Gen Intern Med. 2008 Dec; 23(12):2053-7.
El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc (2003). 2008 Mar-Apr; 48(2):e21-e32.
Issa AM, Phillips KA, Van Bebber S, Nidamarthy HG, Lasser KE, Haas JS, Alldredge BK, Wachter RM, Bates DW. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85.
Alldredge BK, Koda-Kimble MA. Count and be counted: preparing future pharmacists to promote a culture of safety. Am J Pharm Educ. 2006 Aug 15; 70(4):92.
Fenn HH, Sommer BR, Ketter TA, Alldredge B. Safety and tolerability of mood-stabilising anticonvulsants in the elderly. Expert Opin Drug Saf. 2006 May; 5(3):401-16.
Lee KC, Garcia PA, Alldredge BK. Clinical features of status epilepticus in patients with HIV infection. Neurology. 2005 Jul 26; 65(2):314-6.
Phillips KA, Liang SY, Haas JS, Stebbins M, Alldredge BK. Prescription drug dispensing limits and patterns. Manag Care Interface. 2005 Jul; 18(7):41-6.
Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003 May; 2(3):233-47.
Chen JT, Garcia PA, Alldredge BK. Zonisamide-induced restless legs syndrome. Neurology. 2003 Jan 14; 60(1):147.
Alldredge BK, Venteicher R, Calderwood TS. Stability of diazepam rectal gel in ambulance-like environments. Am J Emerg Med. 2002 Mar; 20(2):88-91.
Bourdet SV, Gidal BE, Alldredge BK. Pharmacologic management of epilepsy in the elderly. J Am Pharm Assoc (Wash). 2001 May-Jun; 41(3):421-36.
Alldredge BK. Drug-induced seizures: controversies in their identification and management. Pharmacotherapy. 1997 Sep-Oct; 17(5):857-60.
Alldredge BK, Heard SE, Parko K. Is the prescription really for selegiline? Am J Hosp Pharm. 1994 Apr 01; 51(7):930, 932.
Make a gift
Science is the foun­da­tion of the School of Pharmacy’s pi­o­neer­ing re­search, in­di­vid­ua­lized pa­tient care, and un­par­al­leled PharmD and PhD ed­u­ca­tion pro­grams.
© 2002–2023 The Regents of the University of California